| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE | 2 |
| 1 | OMEPRAZOLE MAGNESIUM | 2 |
| 2 | TACROLIMUS | 2 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 2 |
| 4 | TACROLIMUS OINTMENT 0.1% | 2 |
| 5 | ACETAMINOPHEN | 1 |
| 6 | ACETAMINOPHEN 500MG | 1 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 8 | ADALIMUMAB | 1 |
| 9 | APIXABAN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEBENTAFUSP | 1 | 0.0017 |
| 1 | FERUMOXYTOL | 1 | 0.0005 |
| 2 | QUININE | 1 | 0.0001 |
| 3 | FEBUXOSTAT TABLETS 40 MG | 1 | 0.0001 |
| 4 | FEBUXOSTAT | 1 | 0.0001 |
| 5 | LINAGLIPTIN | 1 | 0.0001 |
| 6 | MYCOPHENILIC ACID | 1 | 0.0000 |
| 7 | BUMETANIDE | 1 | 0.0000 |
| 8 | NALTREXONE | 1 | 0.0000 |
| 9 | MYCOPHENOLIC ACID | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |
| 3 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 1 | 0.0000 |
| 5 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |